Cargando…
Krill Oil Inhibits NLRP3 Inflammasome Activation in the Prevention of the Pathological Injuries of Diabetic Cardiomyopathy
Diabetic cardiomyopathy (DCM) is a common complication of diabetes mellitus (DM), resulting in high mortality. Myocardial fibrosis, cardiomyocyte apoptosis and inflammatory cell infiltration are hallmarks of DCM, leading to cardiac dysfunction. To date, few effective approaches have been developed f...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780413/ https://www.ncbi.nlm.nih.gov/pubmed/35057549 http://dx.doi.org/10.3390/nu14020368 |
_version_ | 1784637831203782656 |
---|---|
author | Sun, Xuechun Sun, Xiaodan Meng, Huali Wu, Junduo Guo, Xin Du, Lei Wu, Hao |
author_facet | Sun, Xuechun Sun, Xiaodan Meng, Huali Wu, Junduo Guo, Xin Du, Lei Wu, Hao |
author_sort | Sun, Xuechun |
collection | PubMed |
description | Diabetic cardiomyopathy (DCM) is a common complication of diabetes mellitus (DM), resulting in high mortality. Myocardial fibrosis, cardiomyocyte apoptosis and inflammatory cell infiltration are hallmarks of DCM, leading to cardiac dysfunction. To date, few effective approaches have been developed for the intervention of DCM. In the present study, we investigate the effect of krill oil (KO) on the prevention of DCM using a mouse model of DM induced by streptozotocin and a high-fat diet. The diabetic mice developed pathological features, including cardiac fibrosis, apoptosis and inflammatory cell infiltration, the effects of which were remarkably prevented by KO. Mechanistically, KO reversed the DM-induced cardiac expression of profibrotic and proinflammatory genes and attenuated DM-enhanced cardiac oxidative stress. Notably, KO exhibited a potent inhibitory effect on NLR family pyrin domain containing 3 (NLRP3) inflammasome that plays an important role in DCM. Further investigation showed that KO significantly upregulated the expression of Sirtuin 3 (SIRT3) and peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α), which are negative regulators of NLRP3. The present study reports for the first time the preventive effect of KO on the pathological injuries of DCM, providing SIRT3, PGC-1α and NLRP3 as molecular targets of KO. This work suggests that KO supplementation may be a viable approach in clinical prevention of DCM. |
format | Online Article Text |
id | pubmed-8780413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87804132022-01-22 Krill Oil Inhibits NLRP3 Inflammasome Activation in the Prevention of the Pathological Injuries of Diabetic Cardiomyopathy Sun, Xuechun Sun, Xiaodan Meng, Huali Wu, Junduo Guo, Xin Du, Lei Wu, Hao Nutrients Article Diabetic cardiomyopathy (DCM) is a common complication of diabetes mellitus (DM), resulting in high mortality. Myocardial fibrosis, cardiomyocyte apoptosis and inflammatory cell infiltration are hallmarks of DCM, leading to cardiac dysfunction. To date, few effective approaches have been developed for the intervention of DCM. In the present study, we investigate the effect of krill oil (KO) on the prevention of DCM using a mouse model of DM induced by streptozotocin and a high-fat diet. The diabetic mice developed pathological features, including cardiac fibrosis, apoptosis and inflammatory cell infiltration, the effects of which were remarkably prevented by KO. Mechanistically, KO reversed the DM-induced cardiac expression of profibrotic and proinflammatory genes and attenuated DM-enhanced cardiac oxidative stress. Notably, KO exhibited a potent inhibitory effect on NLR family pyrin domain containing 3 (NLRP3) inflammasome that plays an important role in DCM. Further investigation showed that KO significantly upregulated the expression of Sirtuin 3 (SIRT3) and peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α), which are negative regulators of NLRP3. The present study reports for the first time the preventive effect of KO on the pathological injuries of DCM, providing SIRT3, PGC-1α and NLRP3 as molecular targets of KO. This work suggests that KO supplementation may be a viable approach in clinical prevention of DCM. MDPI 2022-01-15 /pmc/articles/PMC8780413/ /pubmed/35057549 http://dx.doi.org/10.3390/nu14020368 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sun, Xuechun Sun, Xiaodan Meng, Huali Wu, Junduo Guo, Xin Du, Lei Wu, Hao Krill Oil Inhibits NLRP3 Inflammasome Activation in the Prevention of the Pathological Injuries of Diabetic Cardiomyopathy |
title | Krill Oil Inhibits NLRP3 Inflammasome Activation in the Prevention of the Pathological Injuries of Diabetic Cardiomyopathy |
title_full | Krill Oil Inhibits NLRP3 Inflammasome Activation in the Prevention of the Pathological Injuries of Diabetic Cardiomyopathy |
title_fullStr | Krill Oil Inhibits NLRP3 Inflammasome Activation in the Prevention of the Pathological Injuries of Diabetic Cardiomyopathy |
title_full_unstemmed | Krill Oil Inhibits NLRP3 Inflammasome Activation in the Prevention of the Pathological Injuries of Diabetic Cardiomyopathy |
title_short | Krill Oil Inhibits NLRP3 Inflammasome Activation in the Prevention of the Pathological Injuries of Diabetic Cardiomyopathy |
title_sort | krill oil inhibits nlrp3 inflammasome activation in the prevention of the pathological injuries of diabetic cardiomyopathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780413/ https://www.ncbi.nlm.nih.gov/pubmed/35057549 http://dx.doi.org/10.3390/nu14020368 |
work_keys_str_mv | AT sunxuechun krilloilinhibitsnlrp3inflammasomeactivationinthepreventionofthepathologicalinjuriesofdiabeticcardiomyopathy AT sunxiaodan krilloilinhibitsnlrp3inflammasomeactivationinthepreventionofthepathologicalinjuriesofdiabeticcardiomyopathy AT menghuali krilloilinhibitsnlrp3inflammasomeactivationinthepreventionofthepathologicalinjuriesofdiabeticcardiomyopathy AT wujunduo krilloilinhibitsnlrp3inflammasomeactivationinthepreventionofthepathologicalinjuriesofdiabeticcardiomyopathy AT guoxin krilloilinhibitsnlrp3inflammasomeactivationinthepreventionofthepathologicalinjuriesofdiabeticcardiomyopathy AT dulei krilloilinhibitsnlrp3inflammasomeactivationinthepreventionofthepathologicalinjuriesofdiabeticcardiomyopathy AT wuhao krilloilinhibitsnlrp3inflammasomeactivationinthepreventionofthepathologicalinjuriesofdiabeticcardiomyopathy |